Nicoll A, Timaeus I, Kigadye R M, Walraven G, Killewo J
Communicable Disease Surveillance Centre, Public Health Laboratory Service, London. UK.
AIDS. 1994 Jul;8(7):995-1005. doi: 10.1097/00002030-199407000-00019.
To estimate the effects of the HIV-1 epidemic on mortality in children under 5 years of age in urban and rural populations in eastern and central, and southern Africa.
A lifetable method that allows for the effects of competing causes (i.e., mortality due to HIV and other causes) was used to estimate mortality. Our calculations used published and unpublished data on HIV-1 infection in African adults and children (incidence and prevalence, vertical transmissions, transmission by blood transfusion and natural history), and typical baseline fertility and child mortality data. The results were applied to model rural and urban populations to explore the effects of parameters such as mortality in HIV-1-infected children, fertility in infected mothers and overall population growth.
We estimate that child mortality will rise substantially because of the prevalence of HIV-1 in urban areas. There will be little difference in the absolute levels of increase in mortality between areas in eastern and central, and southern Africa with similar levels of HIV infection; however, in relative terms the effect will be more noticeable in southern Africa because of the lower baseline mortality. Towns with severe epidemics (30% adult seroprevalence) might experience a rise in child mortality of one-third in eastern and central Africa and three-quarters in southern Africa. This will cancel or reverse existing advantages in urban over rural levels of child mortality and this effect will be more pronounced in southern Africa. The exact impact of HIV-1 will vary according to mortality among HIV-1-infected children and to fertility among infected women. However, changes in age structure and population growth have relatively little impact on mortality.
There are likely to be substantial increases in child mortality in sub-Saharan Africa as a result of HIV-1 infection. The main determinant of childhood infection is the scale of the epidemic among adults. Increases in mortality will depend on local adult seroprevalence but are hard to predict precisely because of possible variation in death rates among HIV-1-infected children. In rural areas with low seroprevalence other diseases will remain the main cause of mortality. However, in urban areas families and health services will have to face considerably increased demands from ill and dying children.
评估人类免疫缺陷病毒1型(HIV-1)流行对东部、中部和南部非洲城乡5岁以下儿童死亡率的影响。
采用一种考虑竞争因素(即HIV及其他原因导致的死亡)影响的生命表方法来估计死亡率。我们的计算使用了已发表和未发表的关于非洲成人和儿童HIV-1感染的数据(发病率和患病率、垂直传播、输血传播及自然史),以及典型的基线生育率和儿童死亡率数据。将结果应用于城乡人口模型,以探讨诸如HIV-1感染儿童死亡率、感染母亲生育率和总体人口增长等参数的影响。
我们估计,由于HIV-1在城市地区的流行,儿童死亡率将大幅上升。在HIV感染水平相似的东部、中部非洲地区和南部非洲地区,死亡率上升的绝对水平差异不大;然而,相对而言,由于基线死亡率较低,这种影响在南部非洲将更为明显。在疫情严重的城镇(成人血清阳性率达30%),东部和中部非洲的儿童死亡率可能上升三分之一,南部非洲则上升四分之三。这将抵消或扭转城市儿童死亡率低于农村的现有优势,且这种影响在南部非洲将更为显著。HIV-1的确切影响将因HIV-1感染儿童的死亡率和感染妇女的生育率而异。然而,年龄结构和人口增长的变化对死亡率的影响相对较小。
由于HIV-1感染,撒哈拉以南非洲的儿童死亡率可能会大幅上升。儿童感染率的主要决定因素是成人中的流行规模。死亡率的上升将取决于当地成人血清阳性率,但由于HIV-1感染儿童的死亡率可能存在差异,因此难以精确预测。在血清阳性率较低的农村地区,其他疾病仍将是主要死因。然而,在城市地区,家庭和卫生服务机构将不得不面对病童和垂危儿童带来的大幅增加的需求。